Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 5/20 | 0.42 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.42 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MDK | P21741 | 2/20 | 0.38 |
| ▸ | PTN | P21246 | 1/20 | 0.38 |
| ▸ | BDNF | P23560 | 1/20 | 0.38 |
| ▸ | CD69 | Q07108 | 1/20 | 0.38 |
| ▸ | AMY2A | P04746 | 1/20 | 0.37 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.37 |
| ▸ | FGF1 | P05230 | 1/20 | 0.37 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.36 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18737220 | 0.90 | LGALS3 (0.42) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 | |
| SCHEMBL18257002 | 0.87 | LGALS3 (0.44) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 | |
| SCHEMBL19731923 | 0.87 | LGALS3 (0.48) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 | |
| SCHEMBL17359489 | 0.86 | ALDH1A1 (0.42) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 | |
| SCHEMBL25121361 | 0.86 | MAPK1 (0.44) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 | |
| SCHEMBL12085239 | 0.86 | MAPK1 (0.44) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 | |
| SCHEMBL15215584 | 0.86 | MAPK1 (0.44) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 | |
| SCHEMBL15082697 | 0.86 | MAPK1 (0.44) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 | |
| SCHEMBL21374694 | 0.86 | MAPK1 (0.44) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 | |
| SCHEMBL12213976 | 0.86 | MAPK1 (0.44) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170239358-A1 | Rapid In-situ Gel Forming Compositions Prepared via Reaction of Vinyl Sulfone Derivatized Hyaluronic Acid with Thiol Derivatized Polyethylene Glycol at Alkaline pH | CARBYLAN THERAPEUTICS, INC. | 2017-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170239358-A1 | Rapid In-situ Gel Forming Compositions Prepared via Reaction of Vinyl Sulfone Derivatized Hyaluronic Acid with Thiol Derivatized Polyethylene Glycol at Alkaline pH | CD44, HPSE, VNN1 | LGALS3 1074/4885LGALS8 1565/4885LGALS4 2156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.